Apr 30 |
Lyra Therapeutics GAAP EPS of -$0.35 misses by $0.08, revenue of $0.53M beats by $0.18M
|
Apr 30 |
Lyra Therapeutics, Inc. (LYRA) Reports Q1 Loss, Tops Revenue Estimates
|
Apr 30 |
Lyra Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
|
Apr 26 |
Lyra Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
|
Mar 28 |
Lyra Therapeutics (LYRA) Soars 6.5%: Is Further Upside Left in the Stock?
|
Mar 26 |
Private equity firms who hold 39% of Lyra Therapeutics, Inc. (NASDAQ:LYRA) gained 6.8%, institutions profited as well
|
Mar 25 |
Lyra Therapeutics (LYRA) Is a Great Choice for 'Trend' Investors, Here's Why
|
Mar 23 |
Lyra Therapeutics Inc (LYRA) Posts Year-End Financial Results, Aligns with EPS Projections
|
Mar 22 |
Lyra Therapeutics files for $300M mixed shelf
|
Mar 22 |
Wall Street Analysts See a 101.81% Upside in Lyra Therapeutics (LYRA): Can the Stock Really Move This High?
|